Supira heart support device for high-risk artery stenting
Part of Heart & circulation clinical trials.
This trial tests a new device (the Supira system) that helps support your heart's pumping function during and after a high-risk procedure to open blocked coronary arteries. It is for people with heart failure and complex blockages who may need extra circulatory support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with symptoms (NYHA class II, III, or IV) and a heart pump strength (LVEF) of 45% or less.
- You have one of these serious coronary blockages: left main artery disease, blockage in the only remaining open artery, or blockages in all three major heart arteries.
- Your doctor thinks you would benefit from extra heart support during and after your procedure.
- You do not have a recent stroke (within 6 months) or any stroke with lasting nerve damage.
- You do not have moderate or severe aortic valve disease, severe liver disease, or are on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (Ventiflow LP) that helps support the heart during a procedure to open blocked coronary arteries (angioplasty or PCI) in people whose hearts are weak. It may help those who are too high risk for bypass surgery.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
This study tests whether using a special heart pump (called Impella) during a high-risk procedure to open blocked heart arteries can help protect your heart. It aims to see if this support improves the success and safety of the procedure in people with weak hearts.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This trial is testing whether using a special heart pump (PulseCath iVAC2L) during complex, high-risk angioplasty can help people with very weak hearts. It's for people who need a procedure for complicated coronary artery blockages.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.